The hypothesis that vascular cell proliferation may play an important role in the pathogenesis of cerebral vasospasm has been prominently discussed for more than 15 years, and has been supported by a variety of data that have been presented over those years. We were pleased to see the addition of further support for this concept, in the form of new data showing increased levels of platelet-derived growth factor in the cerebrospinal fluid of patients with subarachnoid hemorrhage.
Response
We wish to thank Drs Simard and Kent for drawing to attention to their work on the effect of calcium channel blockers in preventing proliferation of cerebral smooth muscle cells. 1 The work of Drs Kent and Simard indeed addressed a similar hypothesis to ours, namely, that smooth muscle proliferation contributes to the etiology of cerebral vasospasm. But although our hypotheses were similar, the modes of experimentation were quite different. Drs Kent and Simard studied the mitogenic effects of calcium channel blockers on cultured smooth muscle cells at relatively advanced passage number (passage 10 to 30). In contrast, our studies were confined to patients, whole animal models, and intact human pial arteries in vitro, and focused on the role of platelet-derived growth factors in these systems. Encouragingly, our 2 groups reached similar conclusions from our experiments: that vascular cell proliferation may indeed contribute to the genesis of vasospasm following subarachnoid hemorrhage.
In short, we agree that the conclusions published by Kent et al support the hypothesis that mitogens at the site of a clot may play an important role in the development of cerebral vasospasm. We are grateful to Drs Kent and Simard for pointing out their previous contribution in this area.
